🇺🇸 FDA
Patent

US 12365664

Small molecule inhibitors of SRC tyrosine kinase

granted A61PA61P35/00

Quick answer

US patent 12365664 (Small molecule inhibitors of SRC tyrosine kinase) held by The Board of Regents of the University of Texas System expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P35/00